Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02705560
Other study ID # 347/15
Secondary ID
Status Recruiting
Phase N/A
First received March 5, 2016
Last updated March 5, 2016
Start date August 2015
Est. completion date May 2018

Study information

Verified date March 2016
Source Centre Hospitalier Universitaire Vaudois
Contact François Pralong, MD
Phone 004121 314 05 96
Email francois.pralong@chuv.ch
Is FDA regulated No
Health authority Switzerland: Federal Office of Public Health
Study type Interventional

Clinical Trial Summary

Dietary biomarkers are compounds in biofluids that directly reflect the intake of specific foods or food groups. Their exploration and use in the field of dietary assessments could provide an objective measure of actual intake complementing classical assessment methods (e.g. food frequency questionnaire, 24h recalls). To date, only a limited number of foods have been covered by validated biomarkers.

The study is part of the international project "The Food Biomarker Alliance (FOODBALL)". The study described here has been assigned to assess biomarkers of the intake of milk and cheese. Up to now, there is an evident lack of data on specific and validated biomarkers of milk and cheese (dairy products), which belong to the most relevant public health related foods in Europe. This study will further provide novel insights into the influence of fermentation of milk-based foods on metabolic effects and postprandial adaptations, which has not yet been studied in depth before using cheese as fermented product. Outcomes will support and expand earlier findings on correlation between the intake of fermented dairy products intake and human health.


Description:

This is an acute, randomized, controlled, cross-over study designed to identify dietary biomarkers of milk and cheese intake and to asses metabolic effects after the ingestion of a non-fermented product (milk) and a fermented product (cheese) in healthy subjects.

Twelve healthy participants (six women, six men) in fasted state will consume three different foods in a randomized order on three different study days. Two days prior to each dietary intervention, the run-in period is initiated, during which participants have to follow a restricted diet. Participants will receive a standardised meal for the last dinner during run-in phase. The same meal will be served on the day of the dietary intervention for lunch and for dinner (period of controlled diet). Before and after ingestion of the test foods, blood samples and urine samples will be collected (up to 6 hours). Additionally, 24h-samples will be collected. Primary outcomes (metabolites) will be measured in blood serum and plasma collected at 6 different time points and in urine collected at 7 different time points. Transcriptomics analysis will be performed on whole blood samples collected at 4 time points while clinical chemistry parameters will be assessed in blood samples withdrawn at 6 different time points.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date May 2018
Est. primary completion date June 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Healthy males and females

- Aged 18 - 40 years

- BMI > 18.5 and < 30 kg/m2

- Daily consumption of milk

- No adverse effects after intake of 600 ml of milk

Exclusion Criteria:

- Smokers

- Diagnosed health condition (chronic or infectious disease)

- Taking medication (oral contraceptive pill is allowed)

- Taking nutritional supplements (e.g. vitamins, minerals)

- Pregnant, lactating

- Antibiotics treatment 6 months prior to intervention

- Allergy to milk

- Allergy to soy

- Known intolerance to lactose

- Other food allergies or intolerances (e.g. histamine)

- Anemia (hemoglobin < 120 g/l) at the screening visit

- Iron deficiency (ferritin < 30 µg/l) at the screening visit

- Not willing/able to consume all test foods (milk, cheese and soy drink)

- Not willing/able to consume standardized meals

- Not willing to avoid drinking alcohol during study days

- Not willing to follow nutritional restrictions during study days

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Cow´s milk (3.9% fat, pasteurized)
600 ml full fat milk (organic, pasteurized, 400 kcal)
hard, yellow cheese
100 g Swiss cheese (Le Gruyère medium ripe, 400 kcal)
Soy based drink
600 ml Soy drink (540 ml soy milk (232 kcal) supplemented with 60 ml soy and plant based cream (167 kcal)

Locations

Country Name City State
Switzerland Service of Endocrinology, Diabetes and Metabolism, University Hospital, CHUV Lausanne VD

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Vaudois Agroscope Liebefeld-Posieux Research Station ALP

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identification of dietary biomarkers of cheese and milk intake 24 hours No
Secondary Transcriptomics analyses / gene expression 6 hours No
Secondary Blood cell count and cell type determination 6 hours No
Secondary Glucose 24 hours No
Secondary Insulin 24 hours No
Secondary Triacylglycerides 24 hours No
Secondary Total cholesterol 24 hours No
Secondary HDL cholesterol 24 hours No
Secondary LDL cholesterol 24 hours No
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1